1 of 2
H. Raymond Bingham

A founder of several life-science companies and a former Cadence Design Systems executive have been selected for induction into the Utah Technology Council Hall of Fame.

Dr. Theodore H. Stanley and H. Raymond Bingham will be honored at a dinner event Oct. 24 at the Grand America Hotel. The honorees were named by the council on Wednesday.

Stanley has founded or co-founded eight life-science companies, including Zars and Anesta, and three research and educational foundations. Bingham's career has included serving in several roles at Cadence, including executive vice president, chief financial officer, president, chief executive officer and executive chairman.

"We are honored to recognize these two distinguished gentlemen for their outstanding achievements and the impact they've made to improving not only our way of life in Utah but to improving it throughout the world," Richard Nelson, the council's chief executive officer, said in a prepared statement.

The hall honors people with Utah ties who have made key contributions to the information-technology and life-science industries through new technology, innovation and leadership.

The Oct. 24 black-tie dinner event costs $250 for council members and $400 for nonmembers. Jerry Yang, the chief executive officer, co-founder and self-proclaimed "chief yahoo" of Yahoo, will be the featured speaker. Details are at utahtech.org or 801-568-3500.

Bingham, who graduated from Weber State University, is managing director of equity firm General Atlantic, co-leading its office in Palo Alto, Calif. He also is co-leader of the firm's communications and electronics sector.

His 1993-2005 career at Cadence, an electronics design automation company, saw the company grow from $360 million to $1.3 billion in annual revenues.

Bingham also is a director at Oracle Corp., Flextronics International Ltd. and STMicroelectronics NV.

Stanley, who has served as an anesthesiology professor and research professor of surgery at the University of Utah, is considered an international expert in intravenous anesthesia, opioid analgesics and drug delivery systems, as well as human and wildlife immobilization techniques. Anesta became a public company in 1994 and was sold to Cephalon in 2000 for about $450 million. Stanley invented Anesta's most successful product, Actiq, which resulted in worldwide sales of about $625 million in 2006.

With about $2.5 billion in sales to date, during the past eight years Actiq sales resulted in royalties of about $60 million for the university.


E-mail: bwallace@desnews.com